Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
Biocompatible Drug Delivery System Based on a MOF Platform for a Sustained and Controlled Release of the Poorly
Preety Yadav1, Sarita Kumari1, Anand Yadav1
1Department of Chemistry, School of Basic Sciences, Central University of Haryana, Jant-Pali, Mahendergarh 123031, Haryana, India.
Abstract:
Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of serious concern to the pharmaceutical industry for clinical development. We present here a conceptually new approach to deliver NFX, by loading the drug molecule on the porous platform of a biocompatible metal-organic framework (MOF), MIL-100(Fe). The loading of the drug on the MOF leading to NFX@MIL-100(Fe) was characterized by Fourier transform infrared (FTIR), UV-visible spectroscopy, thermogravimetric analyses (TGA), and nitrogen adsorption studies. Controlled experiments resulted in the high loading of the drug molecule (∼20 wt %) along with the desired sustained release. We could further control the release of norfloxacin by coating drug-loaded MIL-100(Fe) with PEG, PEG{NFX@MIL-100(Fe)}. Both drug delivery systems (DDSs), NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}, were tested for their biocompatibility through toxicity studies. The DDSs are biocompatible and show insignificant cytotoxicity, as revealed by cell viability studies through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Insights
This study developed a new drug delivery system using metal-organic frameworks (MOFs) to improve norfloxacin (NFX) delivery. The biocompatible NFX@MIL-100(Fe) system enhanced drug loading and controlled release, showing potential for pharmaceutical applications.
Area of Science:
- Materials Science
- Nanotechnology
- Pharmaceutical Science
Background:
- Norfloxacin (NFX), a fluoroquinolone antibiotic, exhibits poor solubility and permeability (Biopharmaceutics Classification System Class IV).
- These physicochemical limitations hinder effective drug delivery and pose challenges for pharmaceutical development.
- Developing novel drug delivery systems (DDSs) is crucial for improving the therapeutic efficacy of poorly soluble drugs like NFX.
Purpose of the Study:
- To develop a novel DDS for norfloxacin (NFX) using a biocompatible metal-organic framework (MOF), MIL-100(Fe).
- To characterize the drug-loaded MOF (NFX@MIL-100(Fe)) and evaluate its drug loading capacity and release profile.
- To assess the biocompatibility and cytotoxicity of the developed DDSs.
Main Methods:
- Norfloxacin was loaded onto the MIL-100(Fe) MOF platform.
- Characterization of NFX@MIL-100(Fe) using FTIR, UV-Vis spectroscopy, TGA, and nitrogen adsorption.
- Controlled release studies and PEGylation of NFX@MIL-100(Fe) to create PEG{NFX@MIL-100(Fe)}.
- Biocompatibility and cytotoxicity assessment using MTT assay.
Main Results:
- High drug loading (approximately 20 wt%) of NFX onto MIL-100(Fe) was achieved.
- The NFX@MIL-100(Fe) system demonstrated sustained drug release.
- PEGylation of the DDS further controlled norfloxacin release.
- Toxicity studies confirmed the biocompatibility of both NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)} DDSs with insignificant cytotoxicity.
Conclusions:
- Metal-organic framework MIL-100(Fe) serves as an effective platform for developing a novel drug delivery system for norfloxacin.
- The developed DDSs (NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}) exhibit high drug loading, controlled release, and excellent biocompatibility.
- This approach offers a promising strategy for enhancing the delivery and therapeutic potential of poorly soluble drugs like norfloxacin.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Distribution: Tissue Binding
For...
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...

